Keywords: Bone Therapeutics, Cell therapu manufacgturing, Investment, Skeletal Cell Therapy Support, Bone diseases, Belgium
Bone Therapeutics invests in state-of-the-art cell therapy manufacturing facility and SCTS
Article | 25 February 2013
Belgium-based biopharmaceutical company Bone Therapeutics, focused on innovative cell therapy products for the treatment of bone diseases, says it has ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
